Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers

2014-08-26 22:13:46 | BioPortfolio

Summary

The objectives of this study were:

- to compare the pharmacokinetic profiles of two prototype controlled-release (CR) trazodone hydrochloride (HCl) 300 mg tablets versus two reference products: Trittico® AC (2 x 150 mg CR tablets) and Desyrel® (3 x 100 mg IR (immediate-release) tablets) under fasting condition;

- to assess the controlled release properties of the two prototype formulations;

- to select a prototype formulation for further development;

- to validate the blood sampling schedule for future pivotal pharmacokinetic studies;

- to determine the appropriate sample size for pivotal studies based in the intra-subject variability.

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Healthy

Intervention

Trazodone HCl, Trazodone HCl, Trazodone HCl, Trazodone HCl

Status

Completed

Source

Labopharm Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-26T22:13:46-0400

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily)

The objective of this study was to compare the pharmacokinetic profiles of the test product, 300 mg trazodone hydrochloride (HCl) extended-release caplets (containing Contramid®), when ad...

A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady State

The purpose of this study was to compare the pharmacokinetic profiles at steady state of the test product, 300 mg trazodone hydrochloride (HCl) extended-release caplets (containing Contram...

Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia

The study has a double purpose: a first phase intends to assess the effectiveness and tolerability of trazodone, an antidepressant with sedative and sleep-promoting properties, in the tre...

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.

Trazodone for Sleep Disturbance in Early Alcohol Recovery

This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpat...

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Cellular mechanisms for trazodone-induced cardiotoxicity.

The second-generation selective 5-HT2 receptor antagonists and reuptake inhibitors (SARIs) class antidepressants are known to have fewer cardiovascular side effects than the older ones. However, sever...

Trazodone Effects on Obstructive Sleep Apnea and NREM Arousal Threshold.

Rationale: A low respiratory arousal threshold is a physiological trait involved in obstructive sleep apnea(OSA) pathogenesis. Trazodone may increase arousal threshold without compromising upper airwa...

Low Risk for Switch to Mania during Treatment with Sleep Promoting Antidepressants.

Introduction: Sleep-promoting antidepressants are of interest because they are used not only as antidepressants, but also to promote sleep. Methods: We reviewed case reports describing the switch to m...

Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-kB, p38 and JNK.

Growing evidence suggests that alterations of the inflammatory/immune system contribute to the pathogenesis of major depression and that inflammatory processes may influence the antidepressant treatme...

Outpatient treatment of sleep disorders in Alzheimer patients.

Sleep disorders are common in patients with Alzheimer dementia and affect the quality of life of patients and of their caregivers. Despite the rising number of studies in the area, almost all of them ...

Medical and Biotech [MESH] Definitions

A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)

More From BioPortfolio on "Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers"


Advertisement
 

Relevant Topic

Nutrition
Latest News Clinical Trials Research Drugs Reports Corporate
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Advertisement
 

Searches Linking to this Trial